State Stem Cell Agency Standards Working Group Agenda 12-12-08

Dec 12, 2008
Main Location: 

California Institute for Regenerative Medicine
210 King Street, 3rd Floor
San Francisco, CA 94107

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

MEETING NOTICE AND AGENDA 12-12-08

SCIENTIFIC AND MEDICAL ACCOUNTABILITY STANDARDS WORKING GROUP
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

OPEN SESSION

  1. Welcome from Co-chairs
  2. Call to Order  & Roll Call
  3. Staff Report
      a. Regulatory update / revisions to MES regulations
      b. Update on CIRM Compliance Program
  4. Regulatory and Policy Considerations:
      a. Use of somatic cells in CIRM funded research:
           i. Briefing Paper: Oversight for iPS-Related Research
          ii. Briefing Paper: Payments for Somatic Cells
          iii. Briefing Paper: Consent for Somatic Cells
          iv. Comment: Use of Somatic Cells from Deceased Patients
      b. Use of IVF-embryos for which the gamete donor(s) were paid:
           i. Briefing Paper: Use of IVF Embryos
          ii. Background Research: Policy Analysis
          iii. Original Briefing Paper from 7/20/08 SWG Meeting
  5. Additional Policy Considerations
  6. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine